A vital part of your comprehensive offering for patients with Barrett's esophagus with dysplasia [1,2].
Patients experienced less post-procedure pain and need for narcotic medication [4].
Highly effective and durable response through 2 years:
1-year results:
95% CED
88% CEIM
[2,3]
2-year results:
95% CED
90%CEIM
Ready to ablate a wide range of patients
Highly effective in both naive and refractory patients with Barrett's esophagus
New catheter designs reach tubular structures, gastroesophageal junction (GEJ), and lesions big and small [2]
C2 CryoBalloon™ 90° Standard Catheter ablating treatment naive tissue
C2 CryoBalloon™ Focal Pear Catheter at GEJ
To discover the full C2 CryoBalloon™ experience click here.
1. Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, et al. Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium. Am J Gastroenterol. 2017;112(7):1032-1048.
2. Canto MI, Shaheen NJ, Almario JA, Voltaggio L, Montgomery E, Lightdale CJ. Multifocal nitrous oxide cryoballoon ablation with or without EMR for treatment of neoplastic Barrett’s esophagus (with video). Gastrointest Endosc. 2018. [Epub ahead of print]
3. Canto MI. Safety, efficacy, and durability of endoscopic nitrous oxide cryoballoon ablation for eradication of Barrett’s neoplasia. Poster to be presented at: Digestive Disease Week; June 2-5, 2018. Washington, DC.
4. Van Munster SN, Overwater A, Haidry R, Bisschops R, Bergman J, Weusten BL. CryoBalloon ablation of dysplastic Barrett’s esophagus causes shorter duration and less severe post-procedural pain as compared to radiofrequency ablation. Oral presentation to be presented at: Digestive Disease Week; June 2-5, 2018. Washington, DC.
The day before yesterday, we learned that the Group’s head quarter and several of its business divisions have experienced an IT system incident. The Company will work closely with each of its business divisions and sites, as well as with outside experts, to identify the nature and scope of the incident and to restore the situation as soon as possible.
PENTAX Medical is committed to continuing to be a true partner in education and innovation. That’s why we’re pleased to present the PENTAX INSIGHT Studio Case Reports.
